1. Recalled device: Lifepack defibrillator
Reason for recall: The device may lock up after a defibrillation shock is delivered.
Date of recall: Feb. 1
Devicemaker: Stryker
2. Recalled drug: Infusion bags (Levetiracetam in 0.54 percent sodium chloride injection)
Reason for recall: The infusion bags were mislabeled, saying they contained Levetiracetam in 0.75 percent sodium chloride injection.
Date of recall: Feb. 4
Drugmaker: Dr. Reddy’s Laboratories
3. Recalled drug: Infant ibuprofen
Reason for recall: The affected products may contain a higher concentration of ibuprofen than indicated on the label.
Date of recall: Jan. 29
Drugmaker: Tris Pharma
4. Recalled drug: Baby gripe water
Reason for recall: An undissolved ingredient, citrus flavonoid, was detected. This could be a choking hazard for infants.
Date of recall: Feb. 18
Drugmaker: Kingston Pharma
More articles on pharmacy:
23andMe wants to become a drug company, has 13 drugs in its pipeline: 5 notes
J&J CEO on partnership with Apple: ‘We’re going to save lives’
Medicare would pay for CAR-T therapy under new proposal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
